A comprehensive investigation of PRMT5 in the prognosis and ion channel features of lung cancer
The increasing incidence and mortality associated with lung cancer (LC) is a significant global health challenge. The underlying mechanisms contributing to LC remain inadequately understood. However, emerging evidence suggests that the epigenetic modifier protein arginine methyltransferase 5 (PRMT5)...
Saved in:
| Main Authors: | Yan Wang, Daifang Chu, Haichao Li, Jiangjiang Fan, Ximing Zhu, Yulong Ma, Zhongping Gu, Nianlin Xie, Pengyu Jing |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1478672/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The expression of PRMT5 is associated with postoperative chemotherapeutic outcome in colon cancer
by: Lu Lu, et al.
Published: (2025-04-01) -
PRMT5 inhibitors: Therapeutic potential in pancreatic cancer
by: Carolin Schneider, et al.
Published: (2025-05-01) -
PRMT5 Inhibitor Synergizes with Chemotherapy to Induce Resembling Mismatch Repair Deficiency and Enhance Anti‐TIGIT Therapy in Microsatellite‐Stable Colorectal Cancer
by: Jiang Zhu, et al.
Published: (2025-07-01) -
PRMT1‐mediated arginine methylation promotes YAP activation and hepatocellular carcinoma proliferation
by: Jian Yu, et al.
Published: (2024-12-01) -
PRMT5 promotes cellulase production by regulating the expression of cellulase gene eg2 through histone methylation in Ganoderma lucidum
by: Yefan Li, et al.
Published: (2025-08-01)